Tissue repair

Thérapie par cellules souches pour Plaies et Ulcères Chroniques: coût, données probantes et comment choisir une clinique

Chronic wounds—diabetic foot ulcers, pressure injuries, vascular insufficiency ulcers—fail to close because cellular and molecular processes that normally drive healing are disrupted.

Comment la thérapie par cellules souches est étudiée pour Plaies et Ulcères Chroniques

Chronic wounds—diabetic foot ulcers, pressure injuries, vascular insufficiency ulcers—fail to close because cellular and molecular processes that normally drive healing are disrupted. Inflammation persists unchecked, angiogenesis (new blood-vessel growth) stalls, and the wound remains stuck in an early inflammatory phase, never progressing to tissue remodelling and epithelial closure. Exosomes (nano-scale vesicles secreted by cells and carrying proteins, lipids, and genetic material) have emerged as particularly promising for wound therapy because they cross-link immune signalling with fibroblast activation and growth-factor delivery. Umbilical-cord-derived fibroblasts and placental MSCs contribute direct cellular replacement of damaged dermis and subcutaneous layers. The proposed mechanism combines immunomodulation (damping excessive inflammation), stimulation of local vascular growth, and restoration of extracellular matrix architecture.

Plaies et Ulcères Chroniques: thérapie par cellules souches en un coup d'œil (2026)
Coût indicatif · Bulgarie (UE)€3,000–€8,000
Gamme des coûts du marché mondial€5,000–€15,000 (dvcstem.com)
Principaux types de cellules étudiésExosomes, Fibroblasts from Wharton's Jelly, MSCs from Amniotic Membrane
Statut d'approbationInvestigationnel
Essais enregistrés (ClinicalTrials.gov)59 · 7 recruiting now

For the clinic's own description, see our partner clinic Stem Plus.

Statut d'approbation — Investigationnel: Pour Chronic Wounds & Ulcers, la thérapie par cellules souches n'est pas un remède approuvé dans l'UE ou aux États-Unis — elle est proposée comme un programme investigationnel individualisé. Vérifiez d'abord si un essai clinique enregistré est ouvert pour vous.

Ce que la preuve montre pour Plaies et Ulcères Chroniques

Chronic wound cell and exosome therapy has been subject to 59 completed trials, with 7 currently enrolling participants. Trials span diabetic foot ulcers (majority), pressure wounds, and mixed aetiology chronic wounds. Closure rates (percentage of wounds achieving full epithelial coverage) in treated cohorts typically range from 55–85% over 8–16 weeks, compared to reported historical control rates of 20–40% for advanced wounds. Exosome-based studies specifically show wound-area reduction averaging 45–70% at 12 weeks. Trial heterogeneity in wound selection, cell dose, and delivery (topical, intradermal injection, or fibrin-scaffold embedding) limits meta-analysis.

Clinical-trial reality check (Jun 2026, ClinicalTrials.gov): 59 registered stem-cell trials for Chronic Wounds & Ulcers (7 recruiting now). A registered trial is usually monitored and sometimes free — worth checking before you pay for a private programme. Browse trials ↗

Types de cellules utilisés pour Plaies et Ulcères Chroniques

Depending on assessment, a Chronic Wounds & Ulcers protocol may draw on:

Coût d'un programme Plaies et Ulcères Chroniques

Exosome or cellular wound therapy costs €4,500–8,000 for a full treatment course (typically 2–4 applications spaced 2–4 weeks apart). Baseline imaging (photography, planimetry or 3D scanning), wound cleaning, and offtake samples add €800–1,500. Ongoing dressing costs (specialised antimicrobial or growth-factor-enriched dressings often used post-cell delivery) can reach €300–600 per week for 8–12 weeks, significantly extending total investment.

Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Chronic Wounds & Ulcers cost-by-country breakdown, or compare the best countries for Chronic Wounds & Ulcers →

Peser toutes vos options pour Plaies et Ulcères Chroniques? See the full Chronic Wounds & Ulcers treatment-options comparison — standard care, alternatives and where stem-cell therapy fits, side by side.

Before booking, check safety & regulation, the recovery climate, si vous pourriez être un candidat, and which cell type fits Chronic Wounds & Ulcers.

Questions que les gens posent sur Plaies et Ulcères Chroniques

FAQ complet Plaies et Ulcères Chroniques → · Décomposition des coûts Plaies et Ulcères Chroniques →

Sources et lectures supplémentaires

We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.

Useful tools & guides: Suis-je un candidat? · Quel type de cellule? · Types of clinics & best countries · Calculatrice de coûts

Médicalement examiné par l'équipe éditoriale de StemCellAtlas avec the Stem Plus medical team (physicians & scientists · GMP-certified Sofia laboratory · 25+ yrs international experience) de la clinique partenaire Stem Plus (Sofia), selon les directives ISSCR, FDA et EMA. Educational information, not medical advice; figures indicative.

Thérapie cellulaire de niveau européen, sans les prix européens.

Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.

Évaluation médicale gratuite